Skip to main contentSkip to navigation
Sirius Investors
RaySearch Laboratories AB (publ)

RaySearch Laboratories AB (publ)

RSLBF
OTCHealthcare

RaySearch Laboratories AB (publ) (RSLBF) Financial Metrics

This dashboard provides comprehensive financial metrics and analysis to help evaluate RaySearch Laboratories AB (publ)'s investment potential. View key valuation ratios, profitability metrics, growth indicators, and historical trends to make informed investment decisions.

Financial Metrics Score

Valuation Metrics

Sector benchmarks: Industrials

2025
P/E Ratio
34.29
Weak
WeakModerateStrong
P/B Ratio
7.93
Weak
WeakModerateStrong
Earnings Yield
2.92%
Yield Trap
WeakModerateStrong

Profitability Health

2025
Return on Equity
23.12%
Strong
WeakModerateStrong
Operating Margin
23.94%
Strong
WeakModerateStrong
Net Profit Margin
16.95%
Strong
WeakModerateStrong

Growth Indicators

2025
Revenue Growth
12.77%
Strong
WeakModerateStrong
Net Income Growth
11.93%
Moderate
WeakModerateStrong
EPS Growth
11.95%
Moderate
WeakModerateStrong

Efficiency & Liquidity

2025
Current Ratio
1.70
Moderate
WeakModerateStrong
Quick Ratio
1.66
Strong
WeakModerateStrong
Asset Turnover
0.67x
Moderate
WeakModerateStrong
Inventory Turnover
17.86x
Strong
WeakModerateStrong

Cash Flow & Resilience

Core fortress metrics for cash-rich balance sheets in high-inflation / tech-volatility regimes

2025
Free Cash Flow Yield
4.60%
Strong
WeakModerateStrong
EV / Free Cash Flow
21.73x
Strong
WeakModerateStrong
Net Debt / EBITDA
-0.02x
Strong
WeakModerateStrong
Interest Burden (EBT / EBIT)
0.894
Moderate
WeakModerateStrong
Return on Invested Capital
16.99%
Moderate
WeakModerateStrong
Cash Conversion Cycle
134.55 days
Weak
WeakModerateStrong

Fortress screener guardrails

2/4 passing
  • FCF Yield > 3%
  • Net Debt / EBITDA < 1.5x
  • ROIC > 20%
  • Cash Conversion Cycle < 0 days

Financial Statements

Want to see the complete financial picture? View detailed financial statements including income statements, balance sheets, and cash flow statements for RSLBF.

View Financial Statements